Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Melanoma Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT02419495
What this trial is testing

Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant Solid NeoplasmClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+26 more
M.D. Anderson Cancer Center 221
Testing effectiveness (Phase 2)Ended earlyNCT03991130
What this trial is testing

High Dose IL-2 in Combination With Anti-PD-1

Who this might be right for
MelanomaRenal Cell Carcinoma, Metastatic
Gregory Daniels 6
Early research (Phase 1)Study completedNCT00003792
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Baylor Health Care System
Early research (Phase 1)Study completedNCT02821000
What this trial is testing

Safety and Efficacy Study of Pembrolizumab (MK-3475) in Chinese Participants With Locally Advanced or Metastatic Melanoma (MK-3475-151/KEYNOTE-151)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 103
Early research (Phase 1)Study completedNCT02406183
What this trial is testing

Trial of SBRT With Concurrent Ipilimumab in Metastatic Melanoma

Who this might be right for
MelanomaEffects of ImmunotherapyAdverse Effect of Radiation Therapy
Radiotherapie 13
Early research (Phase 1)Study completedNCT00003022
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+4 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02354690
What this trial is testing

Vemurafenib and TIL Therapy for Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Inge Marie Svane 13
Early research (Phase 1)Ended earlyNCT02714374
What this trial is testing

GL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ Cancers

Who this might be right for
Solid Organ Cancers
Andrew Lowy 5
Testing effectiveness (Phase 2)WithdrawnNCT01851408
What this trial is testing

Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma

Who this might be right for
MelanomaRecurrent MelanomaStage III Melanoma+1 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00492297
What this trial is testing

A Phase II, Multi-Center, Open-Label, Uncontrolled Study to Evaluate the Efficacy and Safety of Sorafenib Given Daily in Combination With Repeated 21-Day Cycles of Dacarbazine (DTIC) Chemotherapy in Subjects With Advanced Metastatic Melanoma

Who this might be right for
Melanoma
Bayer 83
Testing effectiveness (Phase 2)Looking for participantsNCT06319196
What this trial is testing

Clear Me: Interception Trial to Detect and Clear Molecular Residual Disease in Patients With High-risk Melanoma

Who this might be right for
Cutaneous MelanomaMelanoma Stage IVMucosal Melanoma
University Health Network, Toronto 54
Testing effectiveness (Phase 2)Ended earlyNCT02062359
What this trial is testing

T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Melanoma

Who this might be right for
Metastatic CancerMetastatic Melanoma
National Cancer Institute (NCI) 2
Testing effectiveness (Phase 2)Ended earlyNCT00085059
What this trial is testing

Boron Neutron Capture Therapy Using Boronophenylalanine-Fructose Complex in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
European Organisation for Research and Treatment of Cancer - EORTC 4
Testing effectiveness (Phase 2)Study completedNCT00085306
What this trial is testing

Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular Melanoma

Who this might be right for
Stage IV MelanomaRecurrent Melanoma
Case Comprehensive Cancer Center 21
Not applicableStudy completedNCT03416933
What this trial is testing

Therapeutic Drug Monitoring of BRAF-mutated Advanced Melanoma

Who this might be right for
Melanoma (Skin)
Institut de Cancérologie de Lorraine 35
Not applicableLooking for participantsNCT03888950
What this trial is testing

Interim FDG PET-CT in Melanoma Metastatic Patient's Treated by Anti-PD1 Therapy

Who this might be right for
Metastatic Melanoma
Centre Hospitalier Universitaire de Nice 20
Testing effectiveness (Phase 2)Study completedNCT02009397
What this trial is testing

A Phase I/II Open-Label Study of Ipilimumab and GM-CSF Administered to Unresectable Stage IIIC and Stage IV Melanoma Patients

Who this might be right for
Metastatic Melanoma
University of Louisville 27
Testing effectiveness (Phase 2)Study completedNCT00139360
What this trial is testing

Efficacy of Bevacizumab Monotherapy in Treatment of Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Haukeland University Hospital 35
Testing effectiveness (Phase 2)Study completedNCT00804908
What this trial is testing

A Study Evaluating Efficacy of ABT-888 in Combination With Temozolomide in Metastatic Melanoma

Who this might be right for
MelanomaMetastatic MelanomaSkin Cancer
AbbVie (prior sponsor, Abbott) 346
Testing effectiveness (Phase 2)Looking for participantsNCT07155317
What this trial is testing

Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial

Who this might be right for
Advanced Acral MelanomaAdvanced Cutaneous MelanomaAdvanced Mucosal Melanoma+7 more
Emory University 99
Next Page